TopPodcast.com
Menu
  • Home
  • Top Charts
  • Top Networks
  • Top Apps
  • Top Independents
  • Top Podfluencers
  • Top Picks
    • Top Business Podcasts
    • Top True Crime Podcasts
    • Top Finance Podcasts
    • Top Comedy Podcasts
    • Top Music Podcasts
    • Top Womens Podcasts
    • Top Kids Podcasts
    • Top Sports Podcasts
    • Top News Podcasts
    • Top Tech Podcasts
    • Top Crypto Podcasts
    • Top Entrepreneurial Podcasts
    • Top Fantasy Sports Podcasts
    • Top Political Podcasts
    • Top Science Podcasts
    • Top Self Help Podcasts
    • Top Sports Betting Podcasts
    • Top Stocks Podcasts
  • Podcast News
  • About Us
  • Podcast Advertising
  • Contact
Not in our directory?
Add Show Here
Podcast Equipment
Center

toppodcastlogoOur TOPPODCAST Picks

  • Comedy
  • Crypto
  • Sports
  • News
  • Politics
  • True Crime
  • Business
  • Finance

Follow Us

toppodcastlogoStay Connected

    View Top 200 Chart
    Back to Rankings Page
    Government

    DC EKG

    Join former White House policy expert Joe Grogan as he cuts through the complexities of healthcare legislation and its real-world implications. Each episode of DC EKG aims to demystify the policies shaping our healthcare system, uncovering how these changes impact patients, providers, and payers across the country.

    Advertise

    Copyright: All Rights Reserved ©2026

    • Apple Podcasts
    • Google Play
    • Spotify

    Latest Episodes:
    Dan Troy on the FDA, Free Speech, and the Future of Drug Innovation Jul 21, 2025
    Show notes

    In this episode of DC EKG, host Joe Grogan sits down with Dan Troy, former Chief Counsel of the FDA and a nationally recognized expert on healthcare law and the First Amendment. They explore Troy’s unique journey from free speech litigator to one of the FDA’s top legal voices, examining how the agency regulates what drugmakers, doctors, and companies are allowed to say—and what they’re not. The conversation dives into the legal boundaries of off-label promotion, the impact of direct-to-consumer advertising on patient care, and the growing tension between innovation and regulation in the pharmaceutical industry. Troy also offers his perspective on the Inflation Reduction Act and its potential chilling effect on drug development, underscoring the need for bipartisan support in shaping healthcare policy.


    How to Rescue Medicare and Rebuild America’s Health Insurance Market with Michael Cannon Jun 11, 2025
    Show notes

    In this episode, Michael F. Cannon, the Cato Institute’s Director of Health Policy Studies, dives into the policy decisions that shaped Medicare and fundamentally distorted the U.S. health insurance market. From how tax incentives nudged Americans into employer-sponsored plans to the unintended consequences that left many seniors uninsured, Cannon breaks down the government’s role in creating systemic challenges in health care. He also explores how tax policy has long been used as a tool to mandate certain health behaviors, and what a less distorted, freer market might look like. If you want to understand the policy roots behind today’s health care complexities, this conversation is a must-listen.


    Peter Pitts on Navigating FDA Bureaucracy and Unlocking Health Innovation May 23, 2025
    Show notes

    In this conversation, Joe Grogan interviews Peter Pitts, a former FDA associate commissioner and current president of the Center for Medicine and the Public Interest. They discuss the role of FDA advisory committees, the importance of transparency in regulatory processes, and the intersection of vaccination and nutrition in public health. Pitts emphasizes the need for better dosing guidelines for obese patients and the significance of user fees in ensuring predictable FDA reviews. The conversation highlights the challenges and opportunities within the FDA and the broader healthcare landscape.


    Tevi Troy on Power, Politics, and the Fight to Reclaim Big Pharma’s Image May 14, 2025
    Show notes

    In this episode of DC EKG, host Joe Grogan interviews historian and political veteran Tevi Troy about the complex relationship between U.S. presidents and powerful industries. They discuss themes from his book The Power and the Money: The Epic Clashes Between Commanders in Chief and Titans of Industry and his op-ed In Defense of Big Pharma. The conversation explores why pharmaceutical companies are often political targets and the impact on innovation, how historical antitrust cases shape today’s tech and biotech battles, insights on Trump’s leadership and the future of the GOP, the importance of communication skills in politics and business, and behind-the-scenes stories from the Trump administration, offering valuable leadership lessons. This episode provides important insights for policymakers, investors, and anyone interested in the intersection of health, economics, and democracy.


    How to Restore Patient Care in a Broken System with Dr. Anthony DiGiorgio Apr 18, 2025
    Show notes

    Joe Grogan sits down with Dr. Anthony DiGiorgio, a neurosurgeon and health policy researcher, for a wide-ranging conversation on the challenges facing America’s healthcare system. Drawing on his experience at a safety net hospital, Dr. DiGiorgio discusses the realities of trauma care, including the treatment of traumatic brain and spinal cord injuries, and the systemic issues within Medicaid that hinder access and quality of care. The conversation also explores the misuse of the 340B program, the ethics and logistics of overlapping surgeries, and the growing crisis of physician burnout. Dr. DiGiorgio shares his advocacy for direct primary care and the promise of AI as tools to reduce administrative burdens and improve patient outcomes.


    Ryan Long on How the 340B Drug Program Got Hijacked—and What It’s Costing Patients Apr 07, 2025
    Show notes

    In this episode of DC EKG, policy expert Ryan Long unpacks the tangled evolution of the 340B program—from its origins in the early 1990s to its explosive, unintended role in today’s healthcare market. Originally designed to help hospitals serving the uninsured access affordable drugs, 340B has morphed into a tool for profit, driving hospital consolidation, inflating costs, and straining the biotech innovation ecosystem. Ryan explains how vague eligibility rules, lack of oversight, and policy loopholes have turned a small support program into a massive $54 billion industry—with no requirement that savings actually reach the patients it's meant to help. This is a must-listen for anyone interested in how drug pricing policy, hospital behavior, and innovation incentives are shaping the future of medicine in America.


    How Legal Shifts Are Reshaping U.S. Healthcare Policy with Kelly Cleary Apr 06, 2025
    Show notes

    In this episode of DC EKG, host Joe Grogan speaks with Kelly Cleary, a partner at Akin Law, about her career in healthcare regulatory law and her experience at HHS. They discuss the recent repeal of the Richardson waiver, its historical significance, and implications for healthcare policy and regulation. The conversation also touches on the end of Chevron deference and its potential impact on agency regulations, as well as personal reflections on the value of government service in shaping legal practice.


    How Regulatory Reform Can Accelerate Medical Innovation in America with Dr. Brian Miller Mar 21, 2025
    Show notes

    In this episode of DC EKG, host Joe Grogan sits down with Dr. Brian J. Miller to dissect the critical barriers slowing medical innovation in the United States. Together, they unpack the notorious "Valley of Death"—the daunting gap between FDA approval and Medicare coverage that delays patient access to groundbreaking treatments and technologies, often by an average of 5.7 years. Dr. Miller shares his insights on how outdated regulatory processes at both the FDA and CMS create unnecessary hurdles for life sciences and technology entrepreneurs. They explore how modernizing third-party reviews, streamlining clinical trials, and reforming coverage decisions could dramatically accelerate the journey from lab to patient.


    Unpacking the Obamacare Money Laundering Scheme with Brian Blase Mar 04, 2025
    Show notes

    In this episode, Joe Grogan and Brian Blase dive into the current state of Medicaid, exploring the urgent need for reforms to tackle inefficiencies, improper payments, and discriminatory reimbursement rates. Blase discusses the challenges stemming from the Medicaid expansion under the Affordable Care Act (ACA) and how it has impacted traditional enrollees. The conversation also uncovers the troubling issue of Medicaid money laundering, shedding light on the practice of state-directed payments that sometimes surpass Medicare rates. Together, they discuss the pressing need for a more effective and equitable healthcare system that better serves those in need while ensuring accountability in healthcare spending. This episode is a critical look at how the ACA and Medicaid policies are shaping the future of American healthcare.


    Trump’s Healthcare Overhaul & Canada as the 51st State? Sally Pipes Weighs In Feb 13, 2025
    Show notes

    In this episode, Joe Grogan and Sally Pipes dive into the future of U.S. healthcare policy, discussing potential reforms under a second Trump administration. They explore executive orders, Medicaid challenges, and the flaws in Canada’s healthcare system. The conversation also tackles a provocative question: Could Canada ever become the 51st state? Sally breaks down the political, economic, and healthcare implications of such a shift. Plus, they discuss California’s wildfire mismanagement and the urgent need for political change.


    Previous 1 3 4 5 6 7 16 Next

    Related Podcasts

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters

    1

    Inside Strategic Coach: Connecting Entrepreneurs With What Really Matters Business
    WSJ Your Money Briefing

    2

    WSJ Your Money Briefing Business
    FORTUNE Unfiltered with Aaron Task

    3

    FORTUNE Unfiltered with Aaron Task Business
    FORTUNE OnStage Presents: The Most Powerful Women

    4

    FORTUNE OnStage Presents: The Most Powerful Women Business
    Slate Money

    5

    Slate Money Business
    In The Dark – The New Yorker

    6

    In The Dark – The New Yorker Business News
    footer-logo

    Contact Us

    Toll Free: 844-670-7747

    Links

    • Home
    • Top Charts
    • Networks
    • Apps
    • Independents Podcasts
    • Podcast Advertising
    • Podcast News
    • Contact Us
    • About Us
    • Analytics & Insights

    Stay Connected

      Privacy, Terms of Use & Our Code of Ethics Protecting Content Creators Copyrights